ЭНДОТЕЛИАЛЬНЫЕ ПРОГЕНИТОРНЫЕ КЛЕТКИ: УЧАСТИЕ В АНГИОГЕНЕЗЕ И ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ В АУТОЛОГИЧЕСКОЙ КЛЕТОЧНОЙ ТЕРАПИИ АТЕРОСКЛЕРОТИЧЕСКИХ ПОРАЖЕНИЙ СОСУДОВ
https://doi.org/10.51523/2708-6011.2013-10-1-1
Аннотация
В данном обзоре литературы представлены последние данные о биологии эндотелиальных стволовых клеток, их участии в репаративных процессах при атеросклерозе, а также перспективы использования в терапевтическом ангиогенезе.
Об авторах
С. А. Гуреев
Гомельский государственный медицинский университет
Беларусь
Беларусь
Д. А. Зиновкин
Гомельский государственный медицинский университет
Беларусь
Беларусь
Н. Г. Шебушев
Гомельский государственный медицинский университет
Беларусь
Беларусь
Список литературы
1. Van Os, R. Stem cell assay: Something old, something new, something borrowed / R. van Os, L. M. Kamminga, G. de Haan // Stem Cells. - 2004. - Vol. 22. - P. 1181-1190.
2. Xu, Q. Stem cells and transplant atherosclerosis / Q. Xu // Circulation Receach. - 2008. - Vol. 102. - P. 1001-1024.
3. Xu, Q. The impact of progenitor cells in atherosclerosis/ Q. Xu // National Practical Cardiovascular Medicine. - 2006. - № 3. - P. 94-101.
4. Khakoo, A. Y. Endothelial progenitor cells / A. Y. Khakoo, T. Finkel // Annu. Rev. Medicine. - 2005. - Vol. 56. - P. 79-101.
5. Urbrich, C. Endothelial progenitor cells: Characterization and role in vascular biology / C. Urbrich // Circulation Receach. - 2004. - Vol. 95. - P. 343-353.
6. Youder, M. C. Defining human progenitor endothelial cells / M. C. Youder // Journal of Thrombosis and Haemostasis. - 2009. - № 7. - Р. 49-53.
7. Endothelial replacement and angiogenesis in atherosclerotic lesions of allografts are contributed by circulating progenitor cells / Y. Hu [et al.] // Circulation. - 2003. - Vol. 108. - P. 3122-3127.
8. Isolation and characterization of human CD34(-)Lin(~) and CD34(+)Lin(~) hematopoietic stem cells using cell surface markers CD133 and CD7 / L. Gallacher [et al.] // Blood. - 2000. - Vol. 95. - P. 2813-2820.
9. Hill, J. M. Circulating endothelial progenitor stem cells, vascular function, and cardiovascular risk / J. M. Hill // New England Journal of Medicine. - 2003. - Vol. 348. - P. 593-600.
10. Monocyte coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions / A. Schmeisser [et al.] // Cardiovascular Research. - 2001. - Vol. 49. - P. 671-680.
11. A requirement for Flk-1 in primitive and definitive hematopoiesis and vasculogenesis / F. Shalaby [et al.] // Cell. - 1997. - Vol. 89. - P. 981-990.
12. CD34: structure, biology and critical utility / D. S. Krause [et al.] // Blood. - 1996. - Vol. 87. - P. 1-13.
13. CD34-/CD133+/VEGRF-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities / E. B. Friedrich [et al.] // Circulation Research. - 2006. - Vol. 98. - P. 5-20.
14. Dong, C. Endothelial progenitor cells: a promising therapeutic alternativefor cardiovascular disease / C. Dong, P. J. Goldshmidt-Clermont // Journal of Intervascular Cardiology. - 2007. - Vol. 20. - P. 93-99.
15. Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy / D. M. Smadja [et al.] // Cell Biology and Toxicology. - 2007. - № 4. - P. 223-239.
16. Inflammatory and alternatively activated macrophages attract vessel-associated stem cells, relying on HMGB1- and MMP-9-dependent pathways / K. Lolmede [et al.] // Leukocyte Biology. - 2009. - Vol. 85. - P. 779-787.
17. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release ofkit-ligand / B. Heissig [et al.] // Cell. - 2002. - Vol. 109. - P. 625-637.
18. Lataillade, J. J. Stromal cell - derived factor-1 (SDF-1)/ CXCR4 coupleplays multiple roles on haematopoetic progenitors at the border between the old cytokine and new chemokine worlds: survival, cell cycling and trafficking / J. J Lataillade, J. Domenech, M. C. le Bousse-Kerdiles // European Citokine Network. - 2004. - Vol. 15. - P. 177-188.
19. Petit, I. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis / I. Petit, S. Rafil, D. Jin // Trends of Immunology. - 2007. - Vol. 28. - P. 299-307.
20. Stromal cell-derived factor-1 alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in absence injury / J. D. Abbot [et al.] // Circulation. - 2004. - Vol. 110. - P. 3300-3305.
21. Progenitor cells trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 / P. Detelli [et al.] // National Medicine. - 2004. - № 10. - P. 858-864.
22. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells / D. J. Ceradini [et al.] // National Medicine. - 2003. - № 9. - P. 1370-1376.
23. C-kit, by the interacting with the membrane - bound ligand, recruits endothelial progenitor cells to inflamed endothelium/ A. Aicher [et al.] // National Medicine. - 2007. - № 10. - P. 1264-1271.
24. Essential role of HDL on endothelial progenitor cell proliferation with PI3K/Atkt/cyclin D1 as the signal pathway / Q. Zhang [et al.] // ExperimetalBiology Medicine. - 2010. - Vol. 235. - P. 1082-1092.
25. Zampetaki, A. Vascular repair by endothelial progenitor cells / A. Zampetaki, J. P. Kirton, Q. Xu // Cardiovascular Research. - 2008. - Vol. 78. - P. 413-421.
26. Fibrin activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype / H. C. De Doer [et al.] // Arterioscler. Thromb. Vasc. Biol. - 2006. - Vol. 26. - P. 1653-1659.
27. Adherent platelets recruit and induce and differenciation of murine embryonic endothelial progenitor cells and mature endothelial cells in vitro / H. Langer [et al.] // Circulation Research. - 2006. - Vol. 98. - P. 2-10.
28. Potential role of activated platelets in homing of human endothelial progenitor cells of subendothelial matrix / I. E. Lev [et al.] // Thrombosis and Haemostasis. - 2006. - Vol. 96. - Р. 498-504.
29. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells / L. Zeng [et al.] // Cellular Biology. - 2006. - Vol. 174. - P. 1059-1069.
30. Yla-Herttuala, S. Vascular endothelial growth factors: biology and current status of clinical application in cardiovascular medicine / S. Yla-Herttiala, T.T. Russanen, I. Vajanto // JMCC. - 2007. - Vol. 49. - P. 1015-1026.
31. Парфенова, Е. В. Перспективы генной терапии сердечно-сосудистых заболеваний / Е. В. Парфенова, В. А. Ткачук // Вопр. мед. хим. - 2000. - Т. 46. - С. 293-310.
32. Russanen, T. T. Current status of cardiovascular gene therapy / T. T. Russanen, S. Yla-Herttuala // Molecular Therapy. - 2007. - Vol. 15. - P. 1233-1247.
33. Delivery strategies to achieve therapeutic myocardial angiogenesis / R. Kornowski [et al.] // Circulation. - 2000. - Vol. 101. - P. 454-458.
34. Парфенова, Е. В. Поиск новых инструментов для терапевтического ангиогенеза / Е. В. Парфенова // Молекулярная медицина. - 2006. - № 2. - С. 10-23.
35. Tractuev, D. Urokinase gene transfer augments angiogenesis in ishemic skeletal and myocardial mucle // D. Tractuev [et al.] // Molecular Therapy. - 2006. - Vol. 15. - P. 1254-1260.
36. Intracoronary injection of CD133-positive cells enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction / J. Bartunek [et al.] // Circulation. - 2005. - Vol. 112, suppl. I. - P. 178-183.
37. Isolation and transplantation of autologous circulating endothelial progenitor cells intiodenudet vessels and prosthetic grafts: implications for cell based vascular therapy / D. P. Griese [et al.] // Circulation. - 2003. - Vol. 108. - P. 2710-2715.
Рецензия
Для цитирования:
Гуреев С.А., Зиновкин Д.А., Шебушев Н.Г. ЭНДОТЕЛИАЛЬНЫЕ ПРОГЕНИТОРНЫЕ КЛЕТКИ: УЧАСТИЕ В АНГИОГЕНЕЗЕ И ПЕРСПЕКТИВЫ ИСПОЛЬЗОВАНИЯ В АУТОЛОГИЧЕСКОЙ КЛЕТОЧНОЙ ТЕРАПИИ АТЕРОСКЛЕРОТИЧЕСКИХ ПОРАЖЕНИЙ СОСУДОВ. Проблемы здоровья и экологии. 2013;(1):7-11. https://doi.org/10.51523/2708-6011.2013-10-1-1
For citation:
Gureyev S.A., Zinovkin D.A., Shebushev N.G. ENDOTHELIAL PROGENITOR CELLS: THEIR ROLE IN ANGIOGENESIS AND PROSPECTS OF APPLICATION IN AUTOLOGOUS CELL THERAPY OF ATHEROSCLEROTIC VASCULAR DISEASE. Health and Ecology Issues. 2013;(1):7-11. (In Russ.) https://doi.org/10.51523/2708-6011.2013-10-1-1
Просмотров: 280
Послать статью по эл. почте 